Laboratories with More Automated, Fluid Workflow Need Better QC
|
By LabMedica International staff writers Posted on 07 Jan 2010 |
|
The frequency of running quality control (QC) plays a major role in managing patient risk. QC has been run on a time-based frequency due to a batch-based workflow--twice a day, three times a week, etc. However, today's laboratories have migrated from batch analysis to a more automated and fluid workflow; the standard practice of immediate result reporting has compounded the need for appropriate QC strategies so that the time between reporting a result and the next scheduled QC event is optimized.
The American Association for Clinical Chemistry (AACC; Washington DC, USA) announced that a 60-minute webinar would take place on customizing quality control for improved patient safety. It will be held on March 5, 2010, at 14:00 hours (EST).
The program will be supported, in part, by Bio-Rad Laboratories (Plano, TX, USA; www.biorad.com) and Siemens Healthcare Diagnostics (Walpole, MA, USA), and is directed towards members of the media.
Curtis A. Parvin, Ph.D., manager of advanced statistical research, quality systems division, Bio-Rad Laboratories will explain why the traditional batch-based QC practices are not good enough for today's workflow, how laboratories can customize QC practices to their workflow, what QC rules best determine that the laboratory's testing is still in control, and how to maximize patient safety in today's world of immediate result reporting. The program will be followed by a question and answer session.
For more information about the webinar or AACC, please contact Peter Patterson, professional affairs coordinator at AACC (please see related links below).
AACC is a leading professional society dedicated to improving healthcare through laboratory medicine. Its over 9,000 members are clinical laboratory professionals, physicians, research scientists, and others involved in developing tests and directing laboratory operations.
Related Links:
American Association of clinical chemistry
Bio-Rad Laboratories
Siemens Healthcare Diagnostics
Contact Mr. Peter Patterson
The American Association for Clinical Chemistry (AACC; Washington DC, USA) announced that a 60-minute webinar would take place on customizing quality control for improved patient safety. It will be held on March 5, 2010, at 14:00 hours (EST).
The program will be supported, in part, by Bio-Rad Laboratories (Plano, TX, USA; www.biorad.com) and Siemens Healthcare Diagnostics (Walpole, MA, USA), and is directed towards members of the media.
Curtis A. Parvin, Ph.D., manager of advanced statistical research, quality systems division, Bio-Rad Laboratories will explain why the traditional batch-based QC practices are not good enough for today's workflow, how laboratories can customize QC practices to their workflow, what QC rules best determine that the laboratory's testing is still in control, and how to maximize patient safety in today's world of immediate result reporting. The program will be followed by a question and answer session.
For more information about the webinar or AACC, please contact Peter Patterson, professional affairs coordinator at AACC (please see related links below).
AACC is a leading professional society dedicated to improving healthcare through laboratory medicine. Its over 9,000 members are clinical laboratory professionals, physicians, research scientists, and others involved in developing tests and directing laboratory operations.
Related Links:
American Association of clinical chemistry
Bio-Rad Laboratories
Siemens Healthcare Diagnostics
Contact Mr. Peter Patterson
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
HPV Molecular Test
BD Onclarity HPV Assay
Hematology Consumables
Bioblood Devices
Latest Technology News
- AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
- Agentic AI Platform Supports Genomic Decision-Making in Oncology
- Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance
- Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
- AI-Enabled Assistant Unifies Molecular Workflow Planning and Support
- AI Tool Automates Validation of Laboratory Software Configuration Changes
- Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
- Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
- Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
- New Platform Captures Extracellular Vesicles for Early Cancer Detection
- Microfluidic Single-Cell Assay Predicts Breast Cancer Risk
- AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer
- Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing
- Noninvasive Sputum Test Detects Early Lung Cancer
- New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
- Rapid Biosensor Detects Drug Sensitivity in Breast Tumors
Channels
Clinical Chemistry
view channel
Saliva-Based Test Detects Biochemical Signs of Sleep Loss
Acute sleep loss impairs cognition and motor skills, raising safety risks that resemble alcohol intoxication. Clinicians currently lack an objective biochemical test to determine when someone is dangerously... Read more
Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
Alzheimer’s disease is typically confirmed and staged with positron emission tomography scans and cerebrospinal fluid testing, procedures that are costly and invasive. Broader access to minimally invasive... Read more
Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
Blood-based screening for Alzheimer’s disease offers a noninvasive, lower-cost alternative to brain imaging or spinal fluid testing, yet its ability to flag the earliest cognitive changes has been unclear.... Read more
Molecular Diagnostics
view channel
New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance
Rapid identification of Ebola infections is essential to limit transmission and guide public health response, yet detection can be difficult when outbreaks involve rare variants. The current outbreaks... Read more
Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead
Lung cancer remains a leading cause of cancer death, and many cases are detected only after symptoms appear. Current screening programs largely target people with a history of smoking, leaving other at-risk... Read more
Hematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read more
Immunology
view channel
Aptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read more
Microbiology
view channel
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more
Automated Blood Culture System Speeds Detection of Bloodstream Infections
Bloodstream infections and sepsis require rapid laboratory detection to guide targeted antimicrobial therapy and reduce mortality. Conventional blood culture workflows can delay actionable results by critical... Read more
Pathology
view channel
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read more
Blood-Based Method Tracks Gene Activity in the Living Brain
Real-time measurement of gene activity in the brain has been limited by assays requiring destructive tissue sampling. Tracking active genes could reveal how the body responds to environmental factors,... Read more
Industry
view channel
Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer
Natera, Inc. (Austin, TX, USA) and CytoDyn Inc. (Vancouver, WA, USA) announced a strategic collaboration focused on metastatic colorectal cancer (mCRC). Under the agreement, Natera will evaluate circulating... Read more
